The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized, open label, multicenter phase 2 study, to evaluate the efficacy of sorafenib (So) in patients (pts) with metastatic renal cell carcinoma (mRCC) after a radical resection of the metastases: RESORT trial.
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Oncology; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer
 
Francesco Cognetti
No Relationships to Disclose
 
Rosalba Miceli
No Relationships to Disclose
 
Michele Milella
No Relationships to Disclose
 
Alessandra Mosca
No Relationships to Disclose
 
Vincenzo Emanuele Chiuri
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen Oncology; Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen Oncology; Pfizer
 
Alessandra Bearz
No Relationships to Disclose
 
Franco Morelli
No Relationships to Disclose
 
Cinzia Ortega
No Relationships to Disclose
 
Francesco Atzori
No Relationships to Disclose
 
Maddalena Donini
No Relationships to Disclose
 
Raffaele Ratta
No Relationships to Disclose
 
Antonia Martinetti
No Relationships to Disclose
 
Rosanna Montone
No Relationships to Disclose
 
Filippo G. De Braud
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Dompè; Ignyta; Novartis; Pfizer; SERVIER; Tiziana Life Sciences
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Menarini; MSD; Novartis; Pfizer; Roche; SERVIER
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Ignyta (Inst); Lilly (Inst); MedImmune (Inst); Merck Serono (Inst); MSD (Inst); Nektar; Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Roche
 
Vera Cappelletti
No Relationships to Disclose
 
Elena Verzoni
Consulting or Advisory Role - Ipsen; Janssen Oncology; Novartis; Pfizer
Speakers' Bureau - Ipsen; Janssen Oncology; Novartis; Pfizer